Brookfield Asset Management enters the final week of June with a notable divergence: the stock slipped just 2% on the week while US-listed peers absorbed far heavier selling pressure.
The peer comparison tells the sharpest story this week. ARES fell 10.5% and OWL dropped 9.5% over the same five sessions that BAM gave back roughly 2%. KKR and BX each fell between 5.5% and 6.1%. The lone outlier on the positive side was GCMG, up 5%. BAM's closest structural peer, BN, tracked it closely — down 2.4% on the week — but the US alternatives complex broadly saw the kind of multiple compression that BAM avoided, at least this time. That relative resilience on a TSX-listed, CAD-denominated asset management platform during a week when global alternative managers were selling off hard is the most interesting setup heading into month-end.
The lending market carries no tension here. Availability is exceptionally loose at 835%, meaning roughly eight shares remain available to borrow for every one already lent out. That ratio has been expanding steadily since late May, when the 52-week tightest reading was recorded around 187–188%. Cost to borrow has retreated sharply — down 51% week-on-week to 0.58% — after a brief spike to nearly 4% at the end of May. Short interest at 0.58% of the free float is minimal and slipped 5% on the week. There is nothing in the lending market that suggests directional conviction against BAM from sophisticated short sellers.
The bullish case rests on fundamental momentum and institutional positioning. The 30-day EPS momentum factor scores in the 90th percentile of the universe — unusually strong for an asset manager at this point in the cycle. The dividend yield factor ranks in the 92nd percentile as well. Together those two reads suggest the market is pricing BAM more as an income compounder than a pure growth trade, which may explain some of the relative outperformance this week as rate-sensitive growth narratives in the alternatives space came under pressure. The stock's PE of 23.5x and P/B of 8.2x have drifted only marginally over the past 30 days, largely stable when US peers were re-rated downward. Brookfield Corporation holds 74.7% of shares, anchoring the float, while Capital Research, TD Asset Management, and Principal Global Investors each added to positions in their most recent filings.
Two insider moves are worth flagging, even if modest in scale. Director Marcel Coutu bought 4,000 shares at CAD 64.30 on June 4, and fellow director Janice Fukakusa picked up 14,800 shares at CAD 65.79 on May 21. Neither trade is large in dollar terms — roughly CAD 185k and CAD 975k respectively — but both came at prices below the current CAD 66.68 and represent direct-market purchases rather than option exercises. The contrast with Partners Value Investments, which sold roughly 332,800 shares across five transactions in January at prices in the CAD 72–73 range, is notable: the January selling was at meaningfully higher levels, while the June buying is happening at a modest discount to those exit prices.
The ORTEX short score has drifted gently lower over the past two weeks, from 37.1 to 35.7 — a direction consistent with the loosening availability and falling cost to borrow. The ORTEX combined score sits at 35.6, modest in absolute terms, but the EPS momentum and dividend rankings suggest the fundamental scoring remains well-supported. The next catalyst with no confirmed date is the next earnings print, where the most recent result in May produced only a 0.18% one-day move — confirming this is not a name the market tends to trade aggressively around results. What to watch through July is whether the discount BAM has established versus its US alternatives peers — roughly three to eight percentage points of relative outperformance just this week — holds as broader risk appetite around private credit and infrastructure fees stabilises or deteriorates further.
See the live data behind this article on ORTEX.
Open BAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
